NM_002047.4:c.1534G>A
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP6BS1BS2
The NM_002047.4(GARS1):c.1534G>A(p.Ala512Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000143 in 1,614,010 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_002047.4 missense
Scores
Clinical Significance
Conservation
Publications
- Charcot-Marie-Tooth disease type 2DInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
- neuronopathy, distal hereditary motor, type 5AInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Illumina, Laboratory for Molecular Medicine
- spinal muscular atrophy, infantile, James typeInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GARS1 | ENST00000389266.8 | c.1534G>A | p.Ala512Thr | missense_variant | Exon 12 of 17 | 1 | NM_002047.4 | ENSP00000373918.3 | ||
| GARS1 | ENST00000675651.1 | c.1534G>A | p.Ala512Thr | missense_variant | Exon 12 of 17 | ENSP00000502513.1 | ||||
| GARS1 | ENST00000675810.1 | c.1432G>A | p.Ala478Thr | missense_variant | Exon 11 of 16 | ENSP00000502743.1 | ||||
| GARS1 | ENST00000675693.1 | c.1366G>A | p.Ala456Thr | missense_variant | Exon 13 of 18 | ENSP00000502174.1 | ||||
| GARS1 | ENST00000675051.1 | c.1333G>A | p.Ala445Thr | missense_variant | Exon 12 of 17 | ENSP00000502296.1 | ||||
| GARS1 | ENST00000674815.1 | c.1165G>A | p.Ala389Thr | missense_variant | Exon 12 of 17 | ENSP00000502799.1 | ||||
| GARS1 | ENST00000674851.1 | c.1165G>A | p.Ala389Thr | missense_variant | Exon 13 of 18 | ENSP00000502451.1 | ||||
| GARS1 | ENST00000444666.6 | n.1534G>A | non_coding_transcript_exon_variant | Exon 12 of 18 | 3 | ENSP00000415447.2 | ||||
| GARS1 | ENST00000674616.1 | n.*1248G>A | non_coding_transcript_exon_variant | Exon 13 of 18 | ENSP00000502408.1 | |||||
| GARS1 | ENST00000674643.1 | n.*634G>A | non_coding_transcript_exon_variant | Exon 13 of 17 | ENSP00000501636.1 | |||||
| GARS1 | ENST00000674737.1 | n.*872G>A | non_coding_transcript_exon_variant | Exon 13 of 18 | ENSP00000502464.1 | |||||
| GARS1 | ENST00000674807.1 | n.1534G>A | non_coding_transcript_exon_variant | Exon 12 of 16 | ENSP00000502814.1 | |||||
| GARS1 | ENST00000675529.1 | n.*1404G>A | non_coding_transcript_exon_variant | Exon 13 of 18 | ENSP00000501655.1 | |||||
| GARS1 | ENST00000675859.1 | n.1534G>A | non_coding_transcript_exon_variant | Exon 12 of 15 | ENSP00000502033.1 | |||||
| GARS1 | ENST00000676088.1 | n.*1476G>A | non_coding_transcript_exon_variant | Exon 14 of 19 | ENSP00000501884.1 | |||||
| GARS1 | ENST00000676140.1 | n.*479G>A | non_coding_transcript_exon_variant | Exon 12 of 17 | ENSP00000502571.1 | |||||
| GARS1 | ENST00000676164.1 | n.*985G>A | non_coding_transcript_exon_variant | Exon 12 of 17 | ENSP00000501986.1 | |||||
| GARS1 | ENST00000676210.1 | n.*823G>A | non_coding_transcript_exon_variant | Exon 13 of 18 | ENSP00000502373.1 | |||||
| GARS1 | ENST00000676259.1 | n.*966G>A | non_coding_transcript_exon_variant | Exon 12 of 17 | ENSP00000501980.1 | |||||
| GARS1 | ENST00000676403.1 | n.1534G>A | non_coding_transcript_exon_variant | Exon 12 of 16 | ENSP00000502681.1 | |||||
| GARS1 | ENST00000674616.1 | n.*1248G>A | 3_prime_UTR_variant | Exon 13 of 18 | ENSP00000502408.1 | |||||
| GARS1 | ENST00000674643.1 | n.*634G>A | 3_prime_UTR_variant | Exon 13 of 17 | ENSP00000501636.1 | |||||
| GARS1 | ENST00000674737.1 | n.*872G>A | 3_prime_UTR_variant | Exon 13 of 18 | ENSP00000502464.1 | |||||
| GARS1 | ENST00000675529.1 | n.*1404G>A | 3_prime_UTR_variant | Exon 13 of 18 | ENSP00000501655.1 | |||||
| GARS1 | ENST00000676088.1 | n.*1476G>A | 3_prime_UTR_variant | Exon 14 of 19 | ENSP00000501884.1 | |||||
| GARS1 | ENST00000676140.1 | n.*479G>A | 3_prime_UTR_variant | Exon 12 of 17 | ENSP00000502571.1 | |||||
| GARS1 | ENST00000676164.1 | n.*985G>A | 3_prime_UTR_variant | Exon 12 of 17 | ENSP00000501986.1 | |||||
| GARS1 | ENST00000676210.1 | n.*823G>A | 3_prime_UTR_variant | Exon 13 of 18 | ENSP00000502373.1 | |||||
| GARS1 | ENST00000676259.1 | n.*966G>A | 3_prime_UTR_variant | Exon 12 of 17 | ENSP00000501980.1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152182Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000521 AC: 13AN: 249558 AF XY: 0.0000295 show subpopulations
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1461828Hom.: 0 Cov.: 31 AF XY: 0.00000825 AC XY: 6AN XY: 727216 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152182Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74340 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1534G>A (p.A512T) alteration is located in exon 12 (coding exon 12) of the GARS gene. This alteration results from a G to A substitution at nucleotide position 1534, causing the alanine (A) at amino acid position 512 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Charcot-Marie-Tooth disease type 2 Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at